Outcome After Thrombectomy and Intravenous Thrombolysis in Patients With Acute Ischemic Stroke
Authors:
- Jens MinnerupJMJens Minnerup
- Heike WerschingHWHeike Wersching
- Anja TeuberATAnja Teuber
- Jürgen WellmannJWJürgen Wellmann
- Jens EydingJEJens Eyding
- Ralph WeberRWRalph Weber
- Gernot ReimannGRGernot Reimann
- Werner WeberWWWerner Weber
- Lars Udo KrauseLKLars Udo Krause
- Tobias KurthTKTobias Kurth
- Klaus BergerKBKlaus Berger
- REVASK InvestigatorsRIREVASK Investigators
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 47 (6) , 1584-1592
Abstract
Background and Purpose—: In patients with ischemic stroke, randomized trials showed a better functional outcome after endovascular therapy with new-generation thrombectomy devices compared with medical treatment, including intravenous thrombolysis. However, effects on mortality and the generalizability of results to routine clinical practice are uncertain. Methods—: In a prospective observational register-based study patients with ischemic stroke treated either with thrombectomy, intravenous thrombolysis, or their combination were included. Primary outcome was the modified Rankin scale score (0 [no symptoms] to 6 [death]) at 3 months. Ordinal logistic regression was used to estimate the common odds ratio as treatment effects (shift analysis). Propensity score matching was applied to compare patients treated either with intravenous thrombolysis alone or with intravenous thrombolysis plus thrombectomy. Results—: Among 2650 recruited patients, 1543 received intravenous thrombolysis, 504 underwent thrombectomy, and 603 received intravenous thrombolysis in combination with thrombectomy. Later time-to-treatment was associated with worse outcomes among patients treated with thrombectomy plus thrombolysis. In 241 pairs of propensity score–matched patients with a proximal intracranial occlusion, thrombectomy plus thrombolysis was associated with improved functional outcome (common odds ratio, 1.84; 95% confidence interval, 1.32–2.57), and reduced mortality (15% versus 33%; P <0.0001) compared with intravenous thrombolysis alone. Results were similar in various sensitivity analyses accounting for missing outcome data and different analytic methods. Conclusions—: Results from this large prospective registry show that also in routine clinical care thrombectomy plus thrombolysis compared with thrombolysis alone improved functional outcome and reduced mortality in patients with ischemic stroke. Earlier treatment was associated with better outcomes.Keywords
This publication has 16 references indexed in Scilit:
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeNew England Journal of Medicine, 2015
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic StrokeNew England Journal of Medicine, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015
- A Trial of Imaging Selection and Endovascular Treatment for Ischemic StrokeNew England Journal of Medicine, 2013
- Endovascular Therapy after Intravenous t-PA versus t-PA Alone for StrokeNew England Journal of Medicine, 2013
- Endovascular Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2013
- Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic StrokeStroke, 2010
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995